Technology

  Market Overview According to MarketGenics , the global Virtual Clinical Trials Market is valued at USD 6.6 billion in 2025 and is projected to reach USD 11.7 billion by 2035 , registering a CAGR of 5.9% during the forecast period. The market is experiencing significant growth as pharmaceutical companies, biotechnology firms, and contract research organizations increasingly adopt decentralized and technology-enabled clinical trial models. Virtual clinical trials leverage digital health technologies, telemedicine, wearable devices, electronic patient-reported outcomes (ePRO), remote patient monitoring, and cloud-based clinical trial platforms to improve patient recruitment, enhance data collection, and reduce operational costs. The growing focus on patient-centric clinical research, advancements in digital healthcare infrastructure, and increasing demand for faster drug development are accelerating the adoption of virtual clinical trials across the global life sciences in...